Whalesbook
Profit Jumps on Exceptional Items
DCM Shriram Ltd. announced a substantial leap in its fourth-quarter net profit, more than doubling year-on-year to ₹369.92 crore. This significant gain was primarily attributed to a one-time deferred tax credit, which flattered the bottom line.
Revenue Growth Offset by Margin Compression
The company's top line showed resilience, with revenue increasing by 11.7% to ₹3,373 crore in the fourth quarter compared to the same period last year. However, this revenue growth was overshadowed by a contraction in profitability at the operational level. Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) saw a 12.9% decline, falling to ₹353.1 crore from ₹405.2 crore. Consequently, the EBITDA margin compressed to 10.5%, down from 13.4% in the prior year's quarter.
Shareholder Returns and Expansion Plans
In recognition of its performance, the board of directors has proposed a final dividend of 200%, equivalent to ₹4 per equity share of ₹2 face value, for the financial year ended March 31, 2026. This recommendation awaits shareholder approval at the upcoming annual general meeting. Beyond shareholder returns, DCM Shriram is also investing in capacity expansion. Its wholly-owned subsidiary, Hindusthan Specialty Chemicals Ltd (HSCL), plans a ₹101 crore investment to boost its formulated resins capacity by 36,000 TPA. The board also approved financial assistance of up to ₹100 crore to HSCL for this expansion.
Market Reaction
Despite the strong headline net profit figure and dividend announcement, the market appeared to digest the margin pressure. Shares of DCM Shriram closed at ₹1,178 on the NSE on Wednesday, down 1.29% from the previous day's close.